Americans rolled out their new economic agenda Monday, calling it a “Better Deal.” For consumers, that might be true. For the pharma industry, not so much.
Democrats rolled out their new economic agenda Monday, calling it a “Better Deal.” For consumers, that might be true. For the pharma industry, not so much.